glp 1 agonist approved for weight loss Market Overview: GLP-1 Agonists and the Obesity Market | Blog Market Overview: GLP-1 Agonists and
Description
Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...
They are primarily used in the management of type 2 diabetes (T2D).
Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
No significant associations were observed for anorexia nervosa, broad depression, major depressive disorder (MDD), or suicide and intentional self-harm
